Flow Cytometry In Oncology And Immunology Market Growth Outlook Through 2024-2033 |Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company

Spread the love

Overview and Scope
Flow cytometry in oncology and immunology refers to a technology and method used in oncology and immunology to analyze and characterize cells based on their physical and chemical properties.

Sizing and Forecast
The flow cytometry in oncology and immunology market size has grown rapidly in recent years. It will grow from $1.89 billion in 2023 to $2.1 billion in 2024 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to advancements in cancer research, immunology research growth, diagnostic applications, rise in autoimmune diseases, drug development and clinical trials.

The flow cytometry in oncology and immunology market size is expected to see rapid growth in the next few years. It will grow to $3.07 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to integration with genomics and proteomics, growing adoption of single-cell analysis, expanding applications in infectious diseases, rise in cancer incidence, point-of-care flow cytometry. Major trends in the forecast period include immunophenotyping for immunotherapy, miniaturization of flow cytometry systems, multiparametric analysis, shift towards spectral flow cytometry, collaborative research initiatives.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/flow-cytometry-in-oncology-and-immunology-global-market-report

Segmentation & Regional Insights
The flow cytometry in oncology and immunology market covered in this report is segmented –

1) By Type: Immunology, Oncology
2) By Technology: Cell-Based Flow Cytometry, Bead-Based Flow Cytometry
3) By Application: Translational Research, Clinical Research
4) By End User: Hospitals, Diagnostic Laboratories, Reference Laboratories, Pharmaceutical And Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Other End Users

North America was the largest region in the flow cytometry in oncology and immunology market in 2023. The regions covered in the flow cytometry in oncology and immunology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12469&type=smp

Major Driver Impacting Market Growth
The increasing prevalence of cancer is expected to propel the growth of flow cytometry in the oncology and immunology market going forward. Cancer is a disease to describe a group of disorders characterized by the uncontrolled growth and spread of abnormal cells in the body. Flow cytometry is a widely used technique in oncology and immunology for studying cancer and immune cells. For instance, in October 2022, in Macmillan Cancer Support, a UK-based healthcare charity organization, 3 million people had cancer in 2020, and it is estimated that it will rise to 3.5 million by 2025 and 4 million by 2030, and 5.3 million by 2040. Therefore, the increasing prevalence of cancer is driving the growth of flow cytometry in the oncology and immunology markets.

Key Industry Players
Major companies operating in the flow cytometry in oncology and immunology market report are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Sartorius AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Sysmex Partec GmbH, OPKO Health Inc., Miltenyi Biotec, NeoGenomics Laboratories Inc., Luminex Corporation, Q2 Solutions LLC, Enzi Biochem Inc., DiaSorin S.p.A,BioLegend Inc., Cytek Biosciences Inc., Cell Signaling Technology Inc., Standard BioTools Inc., Sony Biotechnology Inc., NanoCellect Biomedical Inc., Nexcelom Bioscience LLC, CytoReason.

The flow cytometry in oncology and immunology market report table of contents includes:
1. Executive Summary
2. Flow Cytometry In Oncology And Immunology Market Characteristics
3. Flow Cytometry In Oncology And Immunology Market Trends And Strategies
4. Flow Cytometry In Oncology And Immunology Market – Macro Economic Scenario
5. Global Flow Cytometry In Oncology And Immunology Market Size and Growth
……………….
32. Global Flow Cytometry In Oncology And Immunology Market Competitive Benchmarking
33. Global Flow Cytometry In Oncology And Immunology Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Flow Cytometry In Oncology And Immunology Market
35. Flow Cytometry In Oncology And Immunology Market Future Outlook and Potential Analysis
36. Appendix